Search research articles
Contact Us
Filters
Showing results (31-40 of 174) with videos related to
Page
of 18
Sort By:
Nature Cardiovascular Research
|
May 7, 2025
Preclinical mouse models of immune checkpoint inhibitor-associated myocarditis
Reilly G Fankhauser, Douglas B Johnson, Javid J Moslehi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2018
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Margaret L Axelrod, Rebecca S Cook, Douglas B Johnson, et al.
Breast Cancer Research : BCR
|
October 11, 2021
Artificial image objects for classification of breast cancer biomarkers with transcriptome sequencing data and convolutional neural network algorithms
Xiangning Chen, Daniel G Chen, Zhongming Zhao, et al.
Nature Reviews. Clinical Oncology
|
January 27, 2022
Immune-checkpoint inhibitors: long-term implications of toxicity
Douglas B Johnson, Caroline A Nebhan, Javid J Moslehi, et al.
Breast Cancer Research and Treatment
|
April 16, 2026
Topoisomerase I inhibitor antibody-drug conjugates in breast cancer: the relevance of the DNA damage response to resistance, response, and combination treatment strategies
Dayle K Wang, Julia A Steele, Susan R Opalenik, et al.
Nature Reviews. Clinical Oncology
|
May 18, 2016
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini, Justin M Balko, Ingrid A Mayer, et al.
BMC Genomics
|
November 14, 2006
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors
Justin M Balko, Anil Potti, Christopher Saunders, et al.
Heliyon
|
April 7, 2023
Convolutional neural network for biomarker discovery for triple negative breast cancer with RNA sequencing data
Xiangning Chen, Justin M Balko, Fei Ling, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2019
Tumor genomic alterations in severe-combined immunodeficiency bare-lymphocyte syndrome genes are associated with high mutational burden and disproportional neo-antigen rates
Yu Wang, Douglas B Johnson, Steve Lu, et al.
Cancer Immunology Research
|
May 1, 2020
Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy
Kaustav P Shah, Haocan Song, Fei Ye, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 174) with videos related to
Sort By:
Page
of 18
Nature Cardiovascular Research
|
May 7, 2025
Preclinical mouse models of immune checkpoint inhibitor-associated myocarditis
Reilly G Fankhauser, Douglas B Johnson, Javid J Moslehi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2018
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Margaret L Axelrod, Rebecca S Cook, Douglas B Johnson, et al.
Breast Cancer Research : BCR
|
October 11, 2021
Artificial image objects for classification of breast cancer biomarkers with transcriptome sequencing data and convolutional neural network algorithms
Xiangning Chen, Daniel G Chen, Zhongming Zhao, et al.
Nature Reviews. Clinical Oncology
|
January 27, 2022
Immune-checkpoint inhibitors: long-term implications of toxicity
Douglas B Johnson, Caroline A Nebhan, Javid J Moslehi, et al.
Breast Cancer Research and Treatment
|
April 16, 2026
Topoisomerase I inhibitor antibody-drug conjugates in breast cancer: the relevance of the DNA damage response to resistance, response, and combination treatment strategies
Dayle K Wang, Julia A Steele, Susan R Opalenik, et al.
Nature Reviews. Clinical Oncology
|
May 18, 2016
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini, Justin M Balko, Ingrid A Mayer, et al.
BMC Genomics
|
November 14, 2006
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors
Justin M Balko, Anil Potti, Christopher Saunders, et al.
Heliyon
|
April 7, 2023
Convolutional neural network for biomarker discovery for triple negative breast cancer with RNA sequencing data
Xiangning Chen, Justin M Balko, Fei Ling, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2019
Tumor genomic alterations in severe-combined immunodeficiency bare-lymphocyte syndrome genes are associated with high mutational burden and disproportional neo-antigen rates
Yu Wang, Douglas B Johnson, Steve Lu, et al.
Cancer Immunology Research
|
May 1, 2020
Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy
Kaustav P Shah, Haocan Song, Fei Ye, et al.
Page
of 18